Adam Maeder
Stock Analyst at Piper Sandler
(3.92)
# 521
Out of 4,843 analysts
87
Total ratings
53.33%
Success rate
9.94%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Overweight | $80 → $83 | $78.22 | +6.11% | 15 | May 13, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $2.53 | +58.10% | 4 | May 12, 2025 | |
| TCMD Tactile Systems Technology | Downgrades: Neutral | $25 → $14 | $9.88 | +41.70% | 3 | May 6, 2025 | |
| RMD ResMed | Maintains: Neutral | $260 → $248 | $244.79 | +1.31% | 3 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $670 → $575 | $552.34 | +4.10% | 19 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Reiterates: Overweight | $133 → $145 | $133.58 | +8.55% | 3 | Apr 17, 2025 | |
| RXST RxSight | Initiates: Neutral | $18 | $15.29 | +17.72% | 1 | Apr 15, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $11 → $8.5 | $7.54 | +12.73% | 7 | Mar 18, 2025 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $260 → $233 | $138.20 | +68.60% | 14 | Feb 10, 2025 | |
| M Macy's | Maintains: Hold | $20 → $21 | $11.89 | +76.62% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $3.91 | +104.60% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $7.75 | +158.06% | 8 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.14 | +133.64% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $2.34 | +669.23% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $43.24 | +128.95% | 3 | May 5, 2022 |
Edwards Lifesciences
May 13, 2025
Maintains: Overweight
Price Target: $80 → $83
Current: $78.22
Upside: +6.11%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $2.53
Upside: +58.10%
Tactile Systems Technology
May 6, 2025
Downgrades: Neutral
Price Target: $25 → $14
Current: $9.88
Upside: +41.70%
ResMed
Apr 24, 2025
Maintains: Neutral
Price Target: $260 → $248
Current: $244.79
Upside: +1.31%
Intuitive Surgical
Apr 23, 2025
Maintains: Overweight
Price Target: $670 → $575
Current: $552.34
Upside: +4.10%
Abbott Laboratories
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $133.58
Upside: +8.55%
RxSight
Apr 15, 2025
Initiates: Neutral
Price Target: $18
Current: $15.29
Upside: +17.72%
Vicarious Surgical
Mar 18, 2025
Maintains: Neutral
Price Target: $11 → $8.5
Current: $7.54
Upside: +12.73%
Inspire Medical Systems
Feb 10, 2025
Maintains: Overweight
Price Target: $260 → $233
Current: $138.20
Upside: +68.60%
Macy's
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $11.89
Upside: +76.62%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $3.91
Upside: +104.60%
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $7.75
Upside: +158.06%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.14
Upside: +133.64%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $2.34
Upside: +669.23%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $43.24
Upside: +128.95%